Molecular determinants of the response to therapy in ovarian cancer
Epithelial ovarian cancer (EOC) has the highest mortality rate in the western world among gynecological malignancies. Approximately 70% of patients achieve complete remission after first-line platinum-based therapy, but, unfortunately, almost all patients relapse with resistant disease. Progress has...
Main Author: | Ricci, Francesca |
---|---|
Published: |
Open University
2013
|
Subjects: | |
Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.590820 |
Similar Items
-
Molecular determinants of response to pemetrexed
by: Margetts, Jane
Published: (2011) -
Molecular markers of resistance to chemotherapy in ovarian cancer : statistical issues and study design
by: Hall, Jacqueline A.
Published: (2005) -
Targeting gene therapy to intraperitoneal ovarian carcinoma
by: Morrison, Joanne
Published: (2006) -
Chemokines, leukocytes and human ovarian cancer
by: Negus, R. P. M.
Published: (1998) -
The role of Rab35 in androgen sensitive ovarian cancer
by: Hoo, San Soo
Published: (2013)